120 related articles for article (PubMed ID: 22121785)
1. [Pharmacokinetics of sulfamethoxazole in healthy Han volunteers living at plain and in native Han and Tibetan healthy volunteers living at high altitude].
Li XY; Liu YN; Li YP; Yuan M; Zhu JB
Yao Xue Xue Bao; 2011 Sep; 46(9):1117-22. PubMed ID: 22121785
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacokinetics of sulfamethoxazole in male chinese volunteers at low altitude and acute exposure to high altitude versus subjects living chronically at high altitude: an open-label, controlled, prospective study.
Li XY; Gao F; Li ZQ; Guan W; Feng WL; Ge RL
Clin Ther; 2009 Nov; 31(11):2744-54. PubMed ID: 20110016
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacokinetics of sulfamethoxazole in native Han and Tibetan male Chinese volunteers living at high altitude.
Li XY; Liu YN; Wang XJ; Zhu JB; Yuan M; Li YP; Li YF
Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):263-9. PubMed ID: 22460596
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics and bioavailability of two cotrimoxazole preparations.
Pokrajac M; Miljković B; Simić D; Brzaković B; Galetin A
Pharmazie; 1998 Jul; 53(7):470-2. PubMed ID: 9699223
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of Lidocaine Hydrochloride Metabolized by CYP3A4 in Chinese Han Volunteers Living at Low Altitude and in Native Han and Tibetan Chinese Volunteers Living at High Altitude.
Zhang J; Zhu J; Yao X; Duan Y; Zhou X; Yang M; Li X
Pharmacology; 2016; 97(3-4):107-13. PubMed ID: 26730802
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjects.
Stevens RC; Laizure SC; Williams CL; Stein DS
Antimicrob Agents Chemother; 1991 Sep; 35(9):1884-90. PubMed ID: 1952863
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
8. Circadian changes in pharmacokinetics of sulfamethoxazole administered orally to rabbits.
Choi JS; Jung EJ
Arch Pharm Res; 2001 Aug; 24(4):338-41. PubMed ID: 11534768
[TBL] [Abstract][Full Text] [Related]
9. Multiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers.
Stevens RC; Laizure SC; Sanders PL; Stein DS
Antimicrob Agents Chemother; 1993 Mar; 37(3):448-52. PubMed ID: 8460913
[TBL] [Abstract][Full Text] [Related]
10. Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.
Hutabarat RM; Unadkat JD; Sahajwalla C; McNamara S; Ramsey B; Smith AL
Clin Pharmacol Ther; 1991 Apr; 49(4):402-9. PubMed ID: 2015729
[TBL] [Abstract][Full Text] [Related]
11. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of losartan and its active carboxylic acid metabolite E-3174 in five ethnic populations of China.
Yang L; Guo T; Xia DY; Zhao LS
J Clin Pharm Ther; 2012 Apr; 37(2):226-31. PubMed ID: 21777404
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic changes of oral sulfamethoxazole in rabbits with diabetes mellitus induced by alloxan.
Choi JS; Choi BC
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):332-40. PubMed ID: 11958286
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of trimethoprim and sulfamethoxazole in llamas after orogastric administration.
Snook CS; Poppenga RH; Rudik I; Sweeney RW
J Vet Pharmacol Ther; 2002 Oct; 25(5):383-6. PubMed ID: 12423230
[No Abstract] [Full Text] [Related]
16. [Effects on the pharmacokinetics of furosemide after acute exposure to high altitude at 4010 meters in rats].
Li WB; Wang R; Xie H; Zhang JH; Xie XH; Wu XY; Jia ZP
Yao Xue Xue Bao; 2012 Dec; 47(12):1718-21. PubMed ID: 23460981
[TBL] [Abstract][Full Text] [Related]
17. [Studies of the pharmacokinetics and bioavailability of a new trimethoprim/sulfamethoxazole preparation in healthy volunteers].
Hutt V; Klingmann I; Pabst GU; Salama Z; Nieder M; Jaeger H
Arzneimittelforschung; 1988 Sep; 38(9):1347-50. PubMed ID: 3265624
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of sulfamethoxazole and trimethoprim in donkeys, mules, and horses.
Peck KE; Matthews NS; Taylor TS; Mealey KL
Am J Vet Res; 2002 Mar; 63(3):349-53. PubMed ID: 11911569
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of sulfamethoxazole in co-trimoxazole suspensions containing different thickness agents.
Marchetti JM; Shuhama IK; Bentley MV; Lara EH
Boll Chim Farm; 1999 Oct; 138(9):461-4. PubMed ID: 10682404
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after oral single- and multiple-dose administration to healthy pigs.
Mengelers MJ; van Gogh ER; Huveneers MB; Hougee PE; Kuiper HA; Pijpers A; Verheijden JH; van Miert AS
Vet Res Commun; 2001 Aug; 25(6):461-81. PubMed ID: 11519678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]